Pharmaceutical Excipients Market Size & Growth Analysis (2023 - 2030)

The Pharmaceutical Excipients market at the global level is promised to reach USD 9 billion by 2030 with a CAGR of 7% during the forecast period 2023 - 2030. 

Pharmaceutical excipients are routine inert substances used alongside the active pharmaceutical ingredient (API). The pharmaceutical excipients are the substances that are used to provide simple governance of drug by calculated route, developing dosage conformance, and confirm consistency and control of drug bioavailability and enable strong and replicable physical product. 

COVID-19 Impact on the global Pharmaceutical Excipients Market

The novel coronavirus (COVID-19) has severely affected the pharmaceutical business during the 2022 period. The multiple nations across the globe imposed lockdown which has disturbed the supply chain of raw materials from the manufacturing centers. Due to the pandemic period, drug development and manufacturing have slowed down with extreme effects on the outsourcing of the organizations. 

Post COVID-19, there has been a slight momentum in the pharma businesses especially the need for the drugs like Remdesivir and hydroxychloroquine has resulted in positive results in COVID-19. 

Market Drivers

The global pharmaceutical excipients market is driven by factors like growing demand for potent drug delivery systems, advanced technologies, and the surging adoption of orphan drugs. Introducing various new creative products and the acceptance of nanotechnology in the healthcare domain and the need for pharmaceutical excipients propelling for the research and development activities. In Australia, many of the pharmaceutical industries are being challenged by broad government reforms in structural changes, drug costs, and irregular pricing decisions and reimbursement.

The rising occurrences of chronic diseases and other health diseases, increasing knowledge regarding the medicine formulations, and the growing number of academic and research institutes for manufacturing efficient treatment methods are some of the factors augmenting the pharmaceutical excipients market growth during the historical period. Also, the governments are investing huge capital in the healthcare sector centers to improve the quality of diagnosis and treatment procedures. 

Market Restrains

The pharmaceutical excipients market growth is diminished by limiting investments for research and development by excipients producers and new product launches that could provide high growth potential. The cost of the equipment required for maintaining and installing is increasing that declines the market growth globally.

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REPORT COVERAGE

CLICK HERE TO DOWNLOAD SAMPLE

Competition and Companies

The report provides an extensive competitive analysis and profiles of the key market players such as,

• Lubrizol Corporation

• JRS Pharma GmbH & Co. Kg

• Dupont De Nemours, Inc.

• Roquette Frères

• Ashland Global Holdings Inc.

• Evonik Industries AG

• Innophos Holdings Inc.

• WACKER Chemie AG

• Air Liquide S.A.

• Colorcon Inc.

• DMV-Fonterra Excipients GmbH & Co. Kg

• BASF SE

• Kerry Group PLC

• Croda International

• Associated British Foods PLC

• Archer Daniels Midland Company

• Others ( Analysis in the report is not limited to above mentioned companies )

Market Segmentation

Pharmaceutical Excipients Market - By Product

• Organic

• Inorganic

By product, the organic pharmaceutical excipients segment is likely to dominate the market by 2030 due to the growing use of organic chemicals in different formulations over the pharmaceutical industry.

Pharmaceutical Excipients Market - By Functionality

• Filler/Diluents

• Lubricants

• Disintegrates

• Binders

• Coating

• Glidants

• Others

The filler/diluents functionality segment accounts to hold the largest share in the pharmaceutical excipients market throughout the historical period. The segment growth owes to various benefits offered in developing and producing drugs. Diluents provide more trustworthy drug components like developed coherence upgrades proper flow. 

Binders functionality segment is estimated to have the quickest growth in the pharmaceutical excipients market growth during the period. Binders are capable of targeting active pharmaceutical ingredients achieving superior functionality and provide a competitive advantage. The increasing consumption of binders in the pharmaceutical excipients market resulting in growing demand driving the market growth.

Pharmaceutical Excipients Market - By Dosage Form

• Oral
• Topical
• Parenteral
• Other

The oral formulations pharmaceutical excipients segment is leading the market with the highest share during the forecast period. Oral formulations are the most generally used in drug composition for treating various health conditions. When compared to other dosage forms, oral formulations are the most economical method for governing medicine and simple to manufacture.

Pharmaceutical Excipients Market - By Geography

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Regionally, North America holds a major share in the pharmaceutical excipients market and continues to dominate the market in the region. The market is leading the region in terms of revenue due to the rising demand for solid oral drugs for treating chronic diseases. The U.S and Canada are the major contributors to the pharmaceutical excipients market. The U.S pharmaceutical excipients market is leading the region with the highest share owing to the growing progress of the pharmaceutical industry, new technologies, and active pharmaceutical ingredients are adopted. The Canadian market is likely to have significant growth during the period. The decreased research and development productivity and strict rules have forced manufacturers the focus on developing value-adding products at less cost without comprising quality. 

The European pharmaceutical excipients market is expected to have significant growth during the forecast period attributing to advanced technologies, the existence of key players, and investing huge capital for developing biologics and better dosage forms. The presence of a huge number of pharmaceutical sectors, the prevalence of large medicine agencies based on excipients fuel the market growth in the region. On April 23, 2022, German pharmaceutical company DFE Pharma, launched BioHale, designed to direct global supply challenges for biopharmaceutical industries. The governments of countries like Germany, Italy, and Spain are taking some initiatives to decrease the cost of the drugs which escalates the generic drugs market in the mentioned countries. 

However, Asia-Pacific is the quickest growing region with the largest CAGR rate throughout the timeline period. The factors that drive the region include profitable manpower and less price of the raw materials. The Indian pharmaceutical excipients market is taking the advantage of the growth of the domestic pharmaceutical industry motivating the Japanese pharmaceutical industry. In Japan, the demand for pharmaceutical demand is low, but for years the country is experiencing surging growth. 

Latin America and the Middle East & African regions are said to enlarge with a strong pace over the upcoming years due to growing discretionary expenses with rising treatment care boost the pharmaceutical excipients market growth. The demand for new excipients is propelling the market growth globally.

Recent Market Developments

• In 2018, both the companies, Roquette and Thermo Fisher Scientific made an agreement providing the right to disburse the Roquettes products in the US and Canada.